Nationalität
Österreich, Deutschland
Geburtsjahr
1975
1997
Genetik, Universität Salzburg, B.A.
2000
Molekularbiologie, New York University, M.S.
2003
Promoviert in Molekularbiologie, New York University, Ph.D.
2003–2005
Roche Singapur, Basel, Wien und Mannheim, Roche Management Development Programm «Perspectives»
2005–2008
Roche Diagnostics Österreich, Wien, Leiter Marketing und Verkauf
2008–2011
Roche Diagnostics Schweden, Stockholm, General Manager
2011–2013
Roche Diagnostics Branford and Madison, Lifecycle Leader Sequencing Solutions
2013–2017
Roche Diagnostics Deutschland, Mannheim, und Roche Holding Deutschland, Grenzach, General Manager
2018–2019
Roche Rotkreuz, Globaler Leiter Roche Diagnostics Centralized and Point of Care Solutions
2019–2022
Roche Diagnostics Basel, CEO, Mitglied der Konzernleitung
Januar 2023–Februar 2023
Roche Pharma Basel, ad interim CEO
Seit 2023
Roche-Gruppe, Chief Executive Officer
–
–
Mitglied des Innovationsbeirats von Labor Berlin (Charité und Vivantes)
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.